GO
Loading...

Medtronic Inc

More

  • Final Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 6:16 PM ET

    Allergan rose$. 61 or. 4 percent, to $166.73. Baxter International Inc. rose $1.01 or 1.4 percent, to $75.28. Boston Scientific Corp. rose$. 13 or 1.1 percent, to $12.51.

  • Midday Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 1:21 PM ET

    Allergan rose $1.18 or. 7 percent, to $167.30. Baxter International Inc. rose$. 84 or 1.1 percent, to $75.11. Boston Scientific Corp. rose$. 15 or 1.2 percent, to $12.53.

  • Early Glance: Medical Devices companies Wednesday, 10 Sep 2014 | 10:32 AM ET

    Allergan fell$. 48 or. 3 percent, to $165.65. Baxter International Inc. rose$. 44 or. 6 percent, to $74.71. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.44.

  • Final Glance: Medical Devices companies Tuesday, 9 Sep 2014 | 8:15 PM ET

    Allergan fell$. 82 or. 5 percent, to $166.12. Baxter International Inc. rose$. 05 or. 1 percent, to $74.27. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.38.

  • Midday Glance: Medical Devices companies Tuesday, 9 Sep 2014 | 1:22 PM ET

    Allergan fell$. 14 or. 1 percent, to $166.80. Baxter International Inc. rose$. 12 or. 2 percent, to $74.34. Johnson& Johnson fell$. 16 or. 2 percent, to $103.89.

  • Early Glance: Medical Devices companies Tuesday, 9 Sep 2014 | 10:26 AM ET

    Allergan fell$. 75 or. 4 percent, to $166.19. Baxter International Inc. rose$. 04 or. 1 percent, to $74.26. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.25.

  • Final Glance: Medical Devices companies Monday, 8 Sep 2014 | 6:38 PM ET

    Allergan fell$. 06 or percent, to $166.94. Baxter International Inc. rose$. 02 or percent, to $74.22. Boston Scientific Corp. rose$. 31 or 2.6 percent, to $12.32.

  • Midday Glance: Medical Devices companies Monday, 8 Sep 2014 | 1:36 PM ET

    Allergan fell$. 34 or. 2 percent, to $166.66. Baxter International Inc. rose$. 40 or. 5 percent, to $74.60. Boston Scientific Corp. rose$. 31 or 2.5 percent, to $12.32.

  • Early Glance: Medical Devices companies Monday, 8 Sep 2014 | 10:34 AM ET

    Allergan fell$. 13 or. 1 percent, to $166.87. Baxter International Inc. rose$. 06 or. 1 percent, to $74.26. Boston Scientific Corp. rose$. 14 or 1.2 percent, to $12.15.

  • NEW YORK, Sept 3- Some of the best-known technology investors are looking beyond their tried-and-true Internet plays to bet on healthcare data as the next growth market.

  • Aug 28- Johnson& Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter. Earlier this year, J&J sold another of its units, Ortho-Clinical Diagnostics Inc to private-equity firm Carlyle Group for $4.15 billion.

  • Bankers and lawyers providing takeover advice said on Monday that Burger King Worldwide Inc's intention to move its tax domicile overseas through a so-called inversion deal- in this case the purchase of Canada's Tim Hortons- shouldn't be seen as a sign of a lot more deals to come.

  • Burger King in merger talks with Tim Hortons Sunday, 24 Aug 2014 | 9:28 PM ET

    Burger King is in talks to combine with Tim Hortons in a deal that would create a powerhouse with a market capitalization of roughly $18 billion.

  • *Deal boosts Roche presence in respiratory medicine. LONDON/ ZURICH, Aug 24- Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

  • Roche to purchase InterMune in $8.3 billion deal Sunday, 24 Aug 2014 | 12:27 PM ET

    Biotech firm Roche announced plans Sunday to buy InterMune for $8.3 billion on a fully diluted basis in an all-cash transaction.

  • Aug 19- Medtronic Inc Chief Executive Omar Ishrak defended his company's plan to acquire Dublin- based Covidien Plc in a so-called inversion deal, saying the medical device maker will be able to create more U.S. jobs while still paying substantial taxes once the transaction closes.

  • Stock futures add to gains after CPI, housing starts Tuesday, 19 Aug 2014 | 8:46 AM ET

    U.S. stock-index futures pointed to a higher open on Tuesday, as global markets continued to rebound on waning Ukraine-Russia tensions.

  • Aug 19- Medtronic Inc reported the strongest quarterly U.S. sales growth for its medical devices in five years and said it was committed to completing the acquisition of Irish-domiciled Covidien Plc by the end of the year or early 2015.. Minneapolis- based Medtronic also confirmed its full-year profit and revenue outlook on Tuesday.

  • Early movers: HD, BHP, BAC, URBN, RDEN, LLY & more Tuesday, 19 Aug 2014 | 7:56 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Medtronic first-quarter profit tops expectations Tuesday, 19 Aug 2014 | 7:41 AM ET

    Aug 19- Medtronic Inc on Tuesday reported first-quarter earnings that exceeded analyst expectations on stronger U.S. sales of its medical devices. Excluding one-time items, Medtronic earned 93 a share in the quarter ended July 25. Net earnings fell to $871 million, or 87 cents a share, from $953 million, or 93 cents a share, a year earlier.